Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...
Tech Times

Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Tech Times

NVIDIA AI Trained Itself on a 30B Model: Corrected Its Own Broken Metric Mid-Run

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...